Close Menu
Home » Illumina Stock Drags GenomeWeb Index Down in January

Illumina Stock Drags GenomeWeb Index Down in January

Feb 03, 2020
|
staff reporter

NEW YORK – The GenomeWeb Index fell more than 2 percent in January, reversing the increases of the previous few months.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Test of Antibodies

According to NPR, an antibody-based test could identify people who were exposed to SARS-CoV-2 and either didn't develop symptoms or were misdiagnosed.

New York Rats Through and Through

A sequencing analysis of New York City rats indicates they have adapted to the urban environment there, according to a recent preprint.

Powerhouse of the Cell, Lost

Ars Technica reports that a multicellular eukaryotic parasite has lost its mitochondria.

Science Papers Discuss AI in Drug Discovery, Find Two Red Panda Species

In Science this week: perspective piece says AI can accelerate drug discovery by using genomic and chemical data, and more.

What's Popular?

In Business News

  1. MGI Unveils 'Extreme Throughput' Sequencing Platform at AGBT to Enable $100 Human Genome

  2. Illumina Sues BGI Again, Alleging New CoolMPS Chemistry Infringes SBS Patents

  3. Cepheid, Sherlock Biosciences Partner on SARS-CoV-2 Diagnostic Test

  4. Oxford Nanopore Licenses NuProbe Sample Prep Technology

  5. Guardant Health to Focus on Early Cancer Detection and Monitoring, CDx Development in 2020

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.